SEC Form 4 · accession 0001104659-18-052812
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Shannon
Officer — President & CEO · Director
Period of report
Aug 16, 2018
Accepted (ET)
Aug 20, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 16, 2018 | A | 30,000 | $0.00 | A | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $102.44 | Aug 16, 2018 | A | 90,000 | A | — | Aug 16, 2028 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1Represents a grant of restricted stock which will vest on the third anniversary of the grant date, subject to continued service on such date.
- F2The options vest 25% per year on each anniversary of the grant date, subject to the holder's continued service through such vesting date.